TRIM29 and inflammatory response: Thus, our insights into the role of TRIM29 in controlling enteric RNA virus-induced intestinal inflammation suggest potential therapeutic applications involving targeting TRIM29 to control gut diseases associated with SARS-CoV-2 infection.